文献速递术前评估与围术期医学产科麻醉

地塞米松联合昂丹司琼预防肥胖患者腹腔镜袖状胃切除术后恶心呕吐:随机双盲安慰剂对照研究

Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind placebo-controlled study.
PubMed 文献 · Eur J Anaesthesiol · 2016-01-01

该随机双盲安慰剂对照研究纳入117例肥胖行腹腔镜袖状胃切除术患者,在闭环丙泊酚-瑞芬太尼全凭静脉麻醉下,评价地塞米松4mg联合昂丹司琼4mg预防术后恶心呕吐(PONV)的疗效。结果显示预防组24小时PONV累积发生率为45%(95%CI 34-60),安慰剂组为54%(95%CI 41-67),P=0.35,严重PONV及需补救止吐药比例两组无差异。结论认为该联合方案不能有效预防此类患者的PONV。

要点

  • 肥胖患者袖状胃切除术后24小时PONV发生率预防组45%、安慰剂组54%,差异无统计学意义。
  • 地塞米松4mg联合昂丹司琼4mg未降低严重PONV或补救止吐药需求。
  • 在闭环丙泊酚-瑞芬太尼麻醉下,该预防方案对高危肥胖患者无效。

核心结论

  • 地塞米松联合昂丹司琼不能有效预防肥胖患者腹腔镜袖状胃切除术后PONV或严重PONV。

研究设计与样本

  • 随机、安慰剂对照、单中心、双盲研究,2013年6月至2014年1月在新喀里多尼亚二级医疗中心进行。
  • 共122例患者随机,117例纳入分析(预防组58例,安慰剂组59例,其中92例女性)。
  • 纳入标准:至少具备两项PONV已知危险因素(女性、不吸烟、既往PONV或晕动病史、预期术后阿片类镇痛)。
  • 排除标准:限制使用双频指数(BIS)的疾病。
  • 所有患者均使用同一自动化系统控制丙泊酚和瑞芬太尼进行诱导和维持,根据BIS值调整效应室浓度。

主要发现

  • 预防组24小时PONV发生率为45%(95%CI 34-60),安慰剂组为54%(95%CI 41-67),P=0.35。
  • 严重PONV(呕吐或11点语言评分量表≥4分的恶心)发生率预防组为19%(95%CI 10-32),安慰剂组为20%(95%CI 11-33),P=1。
  • 需补救止吐药的患者比例预防组为55%(95%CI 41-68),安慰剂组为63%(95%CI 49-75),P=0.46。

关键数值与推荐

  • 预防组:气管插管后静脉给予地塞米松4mg,缝皮时给予昂丹司琼4mg;安慰剂组给予安慰剂。
  • 主要终点:24小时PONV和严重PONV的累积发生率。
  • 数据以百分比(95%置信区间)表示。

临床怎么用

  • 对于肥胖患者行腹腔镜袖状胃切除术并在闭环丙泊酚-瑞芬太尼麻醉下,地塞米松联合昂丹司琼的预防方案未能显著降低PONV,临床需考虑其他预防策略。

局限性

  • 单中心研究,样本量有限(117例纳入分析)。
  • 仅评估了地塞米松4mg联合昂丹司琼4mg这一特定方案。
  • 研究时间为2013-2014年,麻醉管理可能与当前实践有差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In obese patients, the incidence of postoperative nausea and vomiting (PONV) following sleeve gastrectomy under titration of total intravenous anaesthesia (TIVA) and the relevance of risk factors to indicate prophylaxis is unknown. OBJECTIVES: The hypothesis was that after automated TIVA, prophylaxis reduces PONV following laparoscopic sleeve gastrectomy. Our objective was to determine the incidence of PONV and evaluate the efficacy of dexamethasone and ondansetron as prophylaxis when automated intravenous anaesthesia is employed. DESIGN: A randomised, placebo-controlled, single-centre, double-blinded study. SETTING: Secondary care centre in New Caledonia from June 2013 to January 2014. PATIENTS: A total of 122 patients were randomised and 117 (92 women) were included in the analysis (58 in the prophylaxis group and 59 in the placebo group). Eligibility criteria included at least two of the known risk factors for PONV: female sex, nonsmoking status, prior history of PONV or motion sickness and expected postoperative opioid analgesia. Exclusion criteria included disorders limiting the use of the bispectral index. INTERVENTIONS: All patients received propofol and remifentanil controlled by the same automated system during induction and maintenance of general anaesthesia. The controller modifies the calculated effect-site concentrations according to bispectral index values. Patients received either intravenous dexamethasone 4 mg after tracheal intubation and ondansetron 4 mg during skin closure, or placebo. MAIN OUTCOME MEASURES: The primary endpoint was the cumulative incidences of 24-h PONV and severe PONV (vomiting or nausea with a score of ≥4 on an 11-point verbal rating scale). Data are presented as percentage (95% confidence interval). RESULTS: PONV in the first 24 h occurred in 45 (34 to 60)% of patients who received prophylaxis and 54 (41 to 67)% in the placebo group (P = 0.35). The numbers of patients who suffered severe PONV [19 (10 to 32)% in the prophylaxis group vs. 20 (11 to 33)%, P = 1, in the placebo group] and who required rescue antiemetic drugs [55 (41 to 68) vs. 63 (49 to 75)%, P = 0.46] were similar between the groups. CONCLUSION: The combination of dexamethasone and ondansetron was not effective in preventing PONV or severe PONV in obese patients undergoing laparoscopic sleeve gastrectomy after TIVA. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT01876290.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Bataille A, Letourneulx JF, Charmeau A, et al. Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind placebo-controlled study. Eur J Anaesthesiol. 2016. PMID: 26866433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。